I’m Professor of Oncology at University of Helsinki and CEO of TILT Biotherapeutics. We perform translational studies in the field of immunotherapy of cancer, with particular emphasis on oncolytic viruses and adoptive cell therapies. We are global leaders in translating lab work into patients, with more than 10 trials and >500 patients treated with viruses developed in the lab. A total of 11 viruses have been taken into patients. Trials have been performed in Finland, many other European countries and the US. I have also founded two biotech companies: Oncos Therapeutics and TILT Biotherapeutics